Show Notes
Summary In this episode, Catherine and Melissa are joined by Eden Rahim, a Portfolio Manager at Next Edge Capital. We explore the dynamic world of biotech investing, the impact of AI on medicine development, and advanced options trading strategies. We discuss recent breakthroughs in Alzheimer's treatment, CRISPR technology, and how to generate yield through options, providing valuable insights for investors and health enthusiasts alike.
Chapters 00:00 Introduction and guest background 01:11 History of biotech industry and cycles 04:36 Biotech market recovery and current outlook 06:07 Factors causing biotech volatility 07:43 What is biotech and how it differs from pharma 09:43 Blockbuster drugs and their impact on biotech 11:51 M&A activity and industry growth 16:06 Recent developments in Alzheimer's treatments 18:16 Ownership and development of Alzheimer's drugs 19:58 Advances in gene editing and CRISPR technology 23:13 AI's role in drug repurposing and discovery 26:13 Risks and rewards in biotech investing 27:09 Key factors in biotech stock selection 38:21 Biotech as an investment opportunity and ETFs 40:03 Interest in CRISPR and gene editing 43:51 Regulatory challenges and future of CRISPR 45:19 Longevity and biotech innovations 48:01 Options trading strategies and yield generation 52:30 Practical options trading insights 54:14 Closing remarks and future discussions
Host descriptions: Catherine Murray, a business newscaster and former Wall Street professional at Goldman, William Blair and Deutsche bank. Dr. Melissa Hershberg, a medical practitioner with a specialized interest in preventive health, weight loss and aesthetic medicine.
Disclaimer: for entertainment purposes only, please do your own research, your own homework and consult with a financial advisor for investment discussions. In addition to consulting with your Family Doctor, Physician, GP or other health care providers before making any health and beauty decisions.
If you would like to join our email list, please reach out to [email protected] and let us know.
More from GETTIN SAVVY - Health, Wealth and Beauty
GETTIN SAVVY: In Health, Wealth and Beauty Episode 61
GETTIN SAVVY: In Health, Wealth and Beauty Episode 60
GETTIN SAVVY: In Health, Wealth and Beauty Episode 59 Show Summary: In this conversation, Melissa shares her busy life balancing family, sports, and work. They discuss her experiences in tennis and pickleball, as well as her approach to investing for her children. The discussion shifts to the bond market, exploring recent trends and the implications of rising interest rates. They also touch on stock investments, particularly in technology, and the importance of understanding market dynamics. Finally, they delve into a new vision solution that Melissa is considering. In this conversation, we also delve into various topics including Warren Buffett's investment strategies, the impact of global events on energy prices, Moderna's breakthrough in cancer treatment, postpartum psychosis, and the importance of understanding drug interactions. They explore how these themes interconnect with current market trends and healthcare advancements, providing insights into investment decisions and health management. $MRNA Chapters: 00:00 Juggling Family and Sports 02:58 Investing in the Future 05:46 Understanding Bond Markets 11:51 Market Trends and Stock Investments 18:05 The Impact of Interest Rates 21:07 Exploring New Solutions for Vision 22:56 Buffett's Investment Strategies and Portfolio Insights 27:39 Impact of Global Events on Energy Prices 27:56 Moderna's Breakthrough in Cancer Treatment 39:50 Postpartum Psychosis and Its Implications 43:59 Drug Interactions and Health Tips
Summary: This episode moves between two major themes: the science of beauty and the state of the markets. Melissa discusses hair loss, skin health, and GLP-1 medications as emerging tools in beauty and dermatology, while Catherine covers earnings, the Fed, AI spending, and major stocks like Google, Amazon, SpaceX, and Ralph Lauren.
Summary: In this episode, we explore recent medical studies, market trends, and innovative health tests, providing insights into how these developments impact our health and investments.